Published in Clin Ophthalmol on December 09, 2011
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology (2008) 8.65
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol (1984) 5.65
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology (2010) 4.60
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology (2010) 4.09
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology (2010) 3.08
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol (2008) 2.52
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol (2003) 2.25
Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology (2007) 2.12
Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol (2007) 1.72
Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand (2006) 1.66
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol (2007) 1.64
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye (Lond) (2008) 1.45
Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. Am J Ophthalmol (2008) 1.45
Anti-VEGF therapy: comparison of current and future agents. Eye (Lond) (2008) 1.37
Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology (2009) 1.29
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol (2004) 1.28
Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology (2007) 1.24
Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol (2004) 1.22
Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina (2007) 1.22
Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev (2008) 1.09
Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol (2010) 1.07
Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol (2003) 1.01
Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg. Retina (2008) 0.89
Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol (2004) 0.88
Update on the treatment of diabetic retinopathy. ScientificWorldJournal (2008) 0.87
Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye. Br J Ophthalmol (2006) 0.81
Anti-VEGF therapeutic approaches for diabetic macular edema. Int Ophthalmol Clin (2009) 0.78
Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. Int Ophthalmol (2008) 0.77
A new approach to the management of diabetic macular edema. Ophthalmology (2010) 0.76
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology (2011) 4.61
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (2007) 2.53
The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol (2002) 2.50
Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol (2006) 2.03
SMARTPHONE-BASED DILATED FUNDUS PHOTOGRAPHY AND NEAR VISUAL ACUITY TESTING AS INEXPENSIVE SCREENING TOOLS TO DETECT REFERRAL WARRANTED DIABETIC EYE DISEASE. Retina (2016) 2.01
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology (2002) 1.78
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Arch Ophthalmol (2002) 1.71
The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina (2004) 1.69
Ultrahigh-resolution optical coherence tomography of surgically closed macular holes. Arch Ophthalmol (2006) 1.67
Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol (2008) 1.64
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Femtosecond laser capsulotomy. J Cataract Refract Surg (2011) 1.60
Wnt signaling promotes Müller cell proliferation and survival after injury. Invest Ophthalmol Vis Sci (2013) 1.60
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Arch Ophthalmol (2002) 1.53
Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology (2005) 1.49
Femtosecond laser-assisted cataract surgery with integrated optical coherence tomography. Sci Transl Med (2010) 1.47
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology (2005) 1.47
Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci (2008) 1.44
The challenge of determining aqueous contamination rate in anterior segment intraocular surgery. Am J Ophthalmol (2004) 1.43
The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy. Retina (2011) 1.39
Intraoperative use of three-dimensional spectral-domain optical coherence tomography. Ophthalmic Surg Lasers Imaging (2010) 1.25
Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol (2005) 1.21
Photoacoustic ocular imaging. Opt Lett (2010) 1.16
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Localized chemical release from an artificial synapse chip. Proc Natl Acad Sci U S A (2004) 1.14
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): five years of screening with telemedicine. Ophthalmic Surg Lasers Imaging Retina (2014) 1.11
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): four-years of screening with telemedicine. Curr Eye Res (2013) 1.11
Automated drusen segmentation and quantification in SD-OCT images. Med Image Anal (2013) 1.08
The Artificial Synapse Chip: a flexible retinal interface based on directed retinal cell growth and neurotransmitter stimulation. Artif Organs (2003) 1.06
Role of genetic factors and inflammation in age-related macular degeneration. Retina (2007) 1.02
Endogenous Scedosporium apiospermum endophthalmitis. Arch Ophthalmol (2007) 1.01
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion. Clin Ophthalmol (2011) 1.01
Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. Am J Clin Oncol (2003) 1.00
Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab. Ophthalmic Surg Lasers Imaging Retina (2015) 1.00
Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina (2007) 1.00
Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology (2003) 1.00
Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol (2005) 0.99
Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina (2008) 0.99
Subconjunctival Air Leakage After Descemet's Stripping Automated Endothelial Keratoplasty(DSAEK) in a Post-Trabeculectomy Eye. Open Ophthalmol J (2009) 0.99
A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema. Ophthalmology (2011) 0.98
Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol (2003) 0.98
Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells. Circulation (2009) 0.97
Traumatic airbag maculopathy. JAMA Ophthalmol (2013) 0.95
Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol (2010) 0.95
Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol (2011) 0.94
Directed retinal nerve cell growth for use in a retinal prosthesis interface. Invest Ophthalmol Vis Sci (2004) 0.92
Localized neurotransmitter release for use in a prototype retinal interface. Invest Ophthalmol Vis Sci (2003) 0.92
Neovascularization in Purtscher's retinopathy. Clin Ophthalmol (2011) 0.90
Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina (2012) 0.88
Selective retinal therapy with microsecond exposures using a continuous line scanning laser. Retina (2011) 0.87
Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol (2002) 0.87
Fluid flow past an aperture in a microfluidic channel. Anal Chem (2004) 0.86
Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head Neck (2014) 0.86
A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy. Am J Ophthalmol (2006) 0.86
Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina (2008) 0.85
Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review. Graefes Arch Clin Exp Ophthalmol (2012) 0.84
An improved optical coherence tomography-derived fundus projection image for drusen visualization. Retina (2014) 0.83
Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study. Ophthalmology (2004) 0.83
A false color fusion strategy for drusen and geographic atrophy visualization in optical coherence tomography images. Retina (2014) 0.82
Quantitative evaluation of drusen on photographs. Ophthalmology (2013) 0.82
AFLIBERCEPT FOR THE TREATMENT OF RETINAL PIGMENT EPITHELIAL DETACHMENTS. Retina (2016) 0.81
Improving the therapeutic window of retinal photocoagulation by spatial and temporal modulation of the laser beam. J Biomed Opt (2011) 0.81
Microcontact printing on human tissue for retinal cell transplantation. Arch Ophthalmol (2002) 0.81
Precision and safety of the pulsed electron avalanche knife in vitreoretinal surgery. Arch Ophthalmol (2003) 0.80
Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy. Retina (2014) 0.80
Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis. Ophthalmic Surg Lasers Imaging (2011) 0.79
Effects of the pulsed electron avalanche knife on retinal tissue. Arch Ophthalmol (2002) 0.79
Multiple myeloma recurrence with optic nerve infiltration diagnosed by vitrectomy, immunohistochemistry, and in situ hybridization. Eur J Ophthalmol (2013) 0.79
Experience With Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration. Ophthalmic Surg Lasers Imaging Retina (2015) 0.79
Intravascular drug delivery with a pulsed liquid microjet. Arch Ophthalmol (2002) 0.78
Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study. Ophthalmic Surg Lasers Imaging (2009) 0.78
Controlling cell adhesion on human tissue by soft lithography. Langmuir (2004) 0.78
Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitis. Int J Inflam (2012) 0.78
Longterm cultures of the aged human RPE do not maintain epithelial morphology and high transepithelial resistance. Graefes Arch Clin Exp Ophthalmol (2011) 0.78
Ultra-high resolution optical coherence tomography of retinal pigment epithelial tear following blunt trauma. Arch Ophthalmol (2006) 0.77
Descemet stripping automated endothelial keratoplasty tissue preparation with femtosecond laser and contact lens. Cornea (2010) 0.77
Posterior scleritis in patients with systemic lupus erythematosus. Retin Cases Brief Rep (2010) 0.77
Fifty years of ophthalmic laser therapy. Arch Ophthalmol (2011) 0.77
Multi-Modal Longitudinal Evaluation of Subthreshold Laser Lesions in Human Retina, Including Scanning Laser Ophthalmoscope-Adaptive Optics Imaging. Ophthalmic Surg Lasers Imaging Retina (2016) 0.76
PROSPECTIVE TRIAL OF ENDOGENOUS FUNGAL ENDOPHTHALMITIS AND CHORIORETINITIS RATES, CLINICAL COURSE, AND OUTCOMES IN PATIENTS WITH FUNGEMIA. Retina (2016) 0.76
Spectral-Domain Optical Coherence Tomography Angiography of Central Retinal Artery Occlusion. Ophthalmic Surg Lasers Imaging Retina (2016) 0.76
Acute retinal necrosis secondary to herpes simplex virus type 2 in neonates. Ophthalmic Surg Lasers Imaging Retina (2015) 0.76
Factors Associated With Poor Response to Aflibercept After Switching From Ranibizumab or Bevacizumab in Neovascular Age-related Macular Degeneration. Ophthalmic Surg Lasers Imaging Retina (2016) 0.76
Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection. Ophthalmic Surg Lasers Imaging (2012) 0.76
Photodynamic therapy for choroidal neovascularization: a review. Retina (2002) 0.76
Risk factors for respiratory depression in patients undergoing retrobulbar block for vitreoretinal surgery. Ophthalmic Surg Lasers Imaging Retina (2015) 0.76
Retinotomy Closure Following Subretinal Stem Cell Transplant With a 30-Gauge Needle. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Panretinal photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol (2012) 0.75
Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging (2012) 0.75
Application of improved homogeneity similarity-based denoising in optical coherence tomography retinal images. J Digit Imaging (2015) 0.75
Automated segmentation of optic disc in SD-OCT images and cup-to-disc ratios quantification by patch searching-based neural canal opening detection. Opt Express (2015) 0.75
THINKING LEAN: Improving Vitreoretinal Clinic Efficiency by Decentralizing Optical Coherence Tomography. Retina (2016) 0.75
Intraocular Nematode Affixed to Posterior Lens Capsule. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75